Bimatoprost in the Treatment of Eyelash Universalis Alopecia Areata

January 2010 in “ International Journal of Trichology ”

T. Ojeda Vila, Francisco José Martínez Martínez

bimatoprost alopecia areata universalis eyelash growth conjunctivitis Latisse

Studysummary In this 1-year study of patients with alopecia areata universalis, researchers found that 0.03% topical bimatoprost led to an acceptable cosmetic response in 43.24% of participants.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on journals.lww.com →

Discuss this study in the Community →

Research cited in this study

9 / 9 results

research Eyelash Growth from Application of Bimatoprost in Gel Suspension to the Base of the Eyelashes

29 citations , May 2010 in “Ophthalmology”

Bimatoprost gel makes eyelashes grow longer, but may cause side effects and should be monitored by an eye doctor.

research Bimatoprost in the Treatment of Eyelash Hypotrichosis

69 citations , April 2010 in “Clinical ophthalmology”

This article reviews the use of bimatoprost for eyelash hypotrichosis and reports its effectiveness in promoting eyelash growth but highlights uncertain efficacy in cases of eyelash alopecia areata.

research Latanoprost in the Treatment of Eyelash Alopecia in Alopecia Areata Universalis

50 citations , December 2009 in “Journal of The European Academy of Dermatology and Venereology”

This study found that latanoprost may be effective for treating eyelash alopecia areata, achieving cosmetically acceptable regrowth in 45% of patients.

research Successful Use of Bimatoprost in the Treatment of Eyelash Alopecia

15 citations , November 2009 in “Clinical and Experimental Dermatology”

This case study describes a 16-year-old girl with alopecia areata affecting her eyelashes and eyebrows, who showed very limited response to treatment with topical mometasone furoate and subsequent partial hair loss upon stopping the treatment.

research Instilled Bimatoprost Ophthalmic Solution in Patients with Eyelash Alopecia Areata

30 citations , August 2009 in “Journal of the American Academy of Dermatology”

This study found that while bimatoprost was safe for 16 weeks, it was not effective for eyelash growth in patients with significant loss due to alopecia areata, though some with less loss experienced growth.

Lack of Efficacy of Topical Latanoprost and Bimatoprost Ophthalmic Solutions in Promoting Eyelash Growth in Patients with Alopecia Areata

research Lack of Efficacy of Topical Latanoprost and Bimatoprost Ophthalmic Solutions in Promoting Eyelash Growth in Patients with Alopecia Areata

55 citations , March 2009 in “Journal of The American Academy of Dermatology”

This study found that latanoprost and bimatoprost, when applied cutaneously to the eyelids, did not induce appreciable eyelash regrowth in patients with alopecia areata over 16 weeks.

research Determination of the Sildenafil Effect on Alopecia Areata in Childhood: An Open-Pilot Comparison Study

12 citations , January 2006 in “Journal of Dermatological Treatment”

This open-pilot study found that topical 1% sildenafil did not show significant hair growth in children with alopecia areata, as outcomes seemed due to spontaneous disease regression.

research Hypertrichosis of the Eyelashes Caused by Bimatoprost

65 citations , November 2004 in “Journal of the American Academy of Dermatology”

This article reports a case where the IOP-lowering drug bimatoprost was associated with eyelash hypertrichosis.

Hypertrichosis and Increased Pigmentation of Eyelashes and Adjacent Hair in the Region of the Ipsilateral Eyelids of Patients Treated with Unilateral Topical Latanoprost

research Hypertrichosis and Increased Pigmentation of Eyelashes and Adjacent Hair in the Region of the Ipsilateral Eyelids of Patients Treated with Unilateral Topical Latanoprost

216 citations , October 1997 in “American Journal of Ophthalmology”

This study found that unilateral topical latanoprost use for glaucoma was associated with hypertrichosis and increased pigmentation of eyelashes in the treated eye compared to the untreated eye.